Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
07/2007
07/17/2007US7244567 Annealing an unblocked primer to a first strand of nucleic acid; annealing a second blocked primer to a second strand of nucleic acid; elongating the nucleic acid along the first strand with a polymerase; terminating the first sequencing primer; deblocking the second primer; and elongating nucleic acid
07/17/2007US7244565 Gene shinc-3 and diagnostic and therapeutic uses thereof
07/17/2007US7244562 RecA assisted detection of mutations, single nucleotide polymorphisms and specific sequences
07/17/2007US7244561 Inhibiting denaturation of nucleic acid duplexes
07/17/2007US7244559 Sequences determination of preferential nucleotide sequences; provide primers and nucleotide sequence patterns, mix, anneal primer to nucleotide sequences, mix nucleotides, determine sequence of sample
07/17/2007US7244434 Expresses all structural proteins of a pestivirus (e.g., BVDV) except for a functional C protein; coding sequences for a signal sequence within the C protein essential for post translational processing are retained or replaced by a sequence for analogous signal sequences from another pestiviral species
07/17/2007US7244429 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
07/17/2007US7244428 PRO1357 antibodies
07/17/2007CA2335359C Xanthene dyes and their application as luminescence quenching compounds
07/17/2007CA2182013C Humanized antibodies against leukocyte adhesion molecule vla-4
07/17/2007CA2145535C Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain
07/12/2007WO2007078039A1 Purification process for chenodeoxycholic acid
07/12/2007WO2007077563A2 Solid-fluid composition
07/12/2007WO2007077562A2 Antiseptic compositions and methods of using same
07/12/2007WO2007077561A2 Compositions and methods for enhancing in-vivo uptake of pharmaceutical agents
07/12/2007WO2007077560A2 Cryoprotective compositions and methods of using same
07/12/2007WO2007050713A3 Blockade of calcium channels
07/12/2007WO2007048067A3 C-kit oncogene mutations in melanoma
07/12/2007WO2007040469A3 Chloroquine coupled compositions and methods for their synthesis
07/12/2007WO2007021933A3 Methods and compositions for use in treating vascular diseases and conditions
07/12/2007WO2006118988A3 Cellular biomarker antioxidant assay and uses thereof
07/12/2007WO2006117596A3 Nucleic acid probes and nucleic acid analog probes
07/12/2007WO2006116458B1 Modified oligoribonucleotide analogs with enhances immunostimulatory activity
07/12/2007WO2006113579A3 Tumor inhibition by modulating sprouty expression or activity
07/12/2007WO2006063072A3 Immunomodulatory compositions, combinations and methods
07/12/2007WO2006055605A3 Method and substances for diagnosing bipolar disorder
07/12/2007WO2006026051A3 Selections of genes and methods of using the same for diagnosis, prognosis and for targeting the therapy of neuroblastoma
07/12/2007WO2006023768A3 Methods and materials for detecting mutations in quasispecies having length polymorphism
07/12/2007WO2006002378A3 Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods
07/12/2007WO2005019409A3 Combinatorial protein library screening by periplasmic expression
07/12/2007WO2005012487A3 Compositions and methods for preparing short rna molecules and other nucleic acids
07/12/2007US20070163009 Polynucleotides encoding phytase polypeptides
07/12/2007US20070163006 determining susceptibility of a potato to after-cooking darkening comprising assaying a potato sample for a nucleic acid molecule encoding a cinnamic acid 4-hydroxylase protein from potato; darkening due to oxidation of an iron-chlorogenic acid complex
07/12/2007US20070163005 Pm29 and lea3 promoters and use in expression of transgenic genes in plants
07/12/2007US20070163002 Fatty acid desaturases and mutant sequences thereof
07/12/2007US20070163000 Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and Ctenocephalides SPP.
07/12/2007US20070162999 Crop Plant Cystatin Proteinase Inhibitors and Methods of Use
07/12/2007US20070162998 CeCPI: taro cysteine protease inhibitor
07/12/2007US20070162994 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof
07/12/2007US20070162993 Geranylgeranyl pyrophosphate synthases
07/12/2007US20070162989 Methods and compositions for treating motor neuron associated disorders
07/12/2007US20070162987 Modulation of body weights; dietetics; eating disorders; for diagnostic and therapeutic implications in homeostasis of body weight and adipose tissue mass
07/12/2007US20070162986 Anf analogue
07/12/2007US20070162984 STARS-a muscle-specific actin-binding protein
07/12/2007US20070161788 Evaluating the genomic plasticity between the nonpathogenic H. influenzae reference strain Rd and 10 clinical isolates, and DNA sequence evidence that reveals an extensive degree of plasticity among all strains
07/12/2007US20070161712 Genes encoding epsilon lycopene cyclase and method for producing bicyclic epsilon carotene
07/12/2007US20070161596 Study and interfererance, diagnosis and treatment of polyglutamine using short interfering nucleic acid for treatment of dementia or siezures or muscular dystrophy
07/12/2007US20070161595 downregulation of the alpha-synuclein gene for the treatment of synucleinopathies; iRNA agents
07/12/2007US20070161594 Compositions and their uses directed to il-4r alpha
07/12/2007US20070161593 Compositions and their uses directed to il-4r alpha
07/12/2007US20070161591 Methods and compositions for treating neurological disease
07/12/2007US20070161590 Methods and sequences to preferentially suppress expression of mutated huntingtin
07/12/2007US20070161589 DNA, RNA or chimeric oligonucleotide that is at least 90% complementary the nucleic acid encoding CD40 antigens, used for inhibiting the expression of CD40 in cells or tissues; antitumor and antiproliferative agents
07/12/2007US20070161587 Cobalamin mediated delivery of nucleic acids, analogs and derivatives thereof
07/12/2007US20070161586 Drug for preventing and treating atherosclerosis
07/12/2007US20070161585 Immunopotentiator and method for enhancing immunoactivity using the same
07/12/2007US20070161561 Factor vii and factir ix polypeptide; blood coagulation; blood disorders
07/12/2007US20070161558 Production of Vascular Endothelial Cell Growth Factor and DNA Encoding Same
07/12/2007US20070161556 Antifungal Therapeutic targets
07/12/2007US20070161549 Glycosylation-deficient hepatocyte growth factor
07/12/2007US20070161547 Modulation of survivin expression
07/12/2007US20070161531 Subtilase variants
07/12/2007US20070161110 Methods for producing minus-strand rna viral vectors using hybrid promoter comprising cytomegalovirus enhancer and chicken beta-actin promoter
07/12/2007US20070161091 Corynebacterium glutamicum genes encoding proteins involved in genetic stability, gene expression, and protein secretion and folding
07/12/2007US20070161087 Glp-1 fusion proteins
07/12/2007US20070161086 Novel ecdysone receptor-based induicible gene expression system
07/12/2007US20070161084 Production of glycoproteins using manganese
07/12/2007US20070161083 Codon Optimized Recombinant Dermaphagoides Allergens
07/12/2007US20070161082 Lipase variants
07/12/2007US20070161081 Hepatocyte growth factor intron fusion proteins
07/12/2007US20070161080 Antibodies
07/12/2007US20070161053 Chimeric human sweet-umami and umami-sweet taste receptors
07/12/2007US20070161046 Truncated aggrecanase molecules
07/12/2007US20070161045 Fusion proteins based upon somatostatin receptors
07/12/2007US20070161037 Isolation and use of ryanodine receptors
07/12/2007US20070161035 Plant Myb Transcription Factor Homologs
07/12/2007US20070161027 Oligonucleotides and analogs labeled with energy transfer dyes
07/12/2007US20070161026 Regents labeled with energy transfer dyes
07/12/2007US20070161025 Methylthioadenosine Phosphorylase Compositions and Methods of Use in the Diagnosis and Treatment of Proliferative Disorders
07/12/2007US20070161021 Novel nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase
07/12/2007US20070161020 Detection of nucleic acids through amplification of surrogate nucleic acids
07/12/2007US20070161014 Nucleic acid binding proteins
07/12/2007US20070161013 Cystic fibrosis transmembrane conductance regulator gene mutations
07/12/2007US20070161011 Using pyrococcus polymerase and labeled probes as tools in detecting and/or measuring nucleic acid
07/12/2007US20070161010 Methods and compositions for mutation analysis
07/12/2007US20070161008 Diagnostic methods for determining treatment
07/12/2007US20070161007 Synthetic cofactor analogs of S-adenosylmethionine as ligatable probes of biological methylation and methods for their use
07/12/2007US20070161004 Methods and compositions involving microRNA
07/12/2007US20070161003 Novel therapeutic targets in cancer
07/12/2007US20070160996 Thrombosis diagnosis/prognosis method
07/12/2007US20070160994 Using immunoglobulin heavy chain expression as evaluative tool in diagnosis of autoimmune, cell proliferative and immunodepressive disorders
07/12/2007US20070160993 Novel centromeric protein shugoshin
07/12/2007US20070160988 Comparative genomic hybridization
07/12/2007US20070160987 Human g protein-coupled receptor and modulators thereof for the treatment of inflammatory disorders
07/12/2007US20070160985 proteins that modulate the growth, differentiation, trafficking and physiology of mammalian cells, e.g., cells of the hematopoietic system and the neuronal system of mammals
07/12/2007US20070160983 Materials and methods for detection of enterovirus and norovirus
07/12/2007US20070160982 Development of influenza a antivirals
07/12/2007US20070160980 Each double stranded siNA sequence is between 19 and 23 nucleotides, directs gene cleavage, has a complementary antisense region, and is derived from a virus chosen from HIV, hepatitis, respiratory syncytial virus (RSV) or influenza; gene therapy
07/12/2007US20070160644 Methods and compositions for promoting attachment of cells of endothelial cell lineage to medical devices
07/12/2007US20070160624 Peptides of the Bacillus anthracis Anthrax Toxin Lethal factor Protein pX01-107; methods of stimulating immune response; antisense agents; vaccine